Found a bug or want a feature? Verified reports earn free credits.
Log inSign up
ListedSMEPharmaceuticals & DrugsMEDISTEP

Medistep Healthcare IPO

Medistep Healthcare IPO is an SME IPO raising ₹16 Cr at a fixed price of ₹43 a share. It listed on 18 Aug 2025 at ₹48, +11.3% against its issue price of ₹43, and trades at ₹23 today (−47.7% since issue). It was subscribed 373× in total.

Get alerts on this companyCompany page
₹43
Issue price
₹23
Price now
−47.7%
Since issue price
18 Aug 2025
Listed on
373×Subscribed (final) · all exchanges

373.3 times more demand than shares on offer

populated partly populated we hold nothing here — the tab says why

How its cohort has done

268 SME issues listed in 2025 that we can price today. This is the group this issue belongs to.

−7.6%
Median return since issue price
54.1%
Now trading below their issue price

Neither figure is a forecast for this issue — they describe what happened to comparable issues. Full cohort analytics →

What we hold for this issue

Stated up front on every issue, so a sparse page reads as a fact about the source rather than a broken one.

Category split — who bidNot available from NSE for this issue
How demand built over timeFinal figure held, but no series — we were not sampling this issue while it was live
Price-point demand curveLive only — NSE stops serving this once bidding closes
Lead managers and registrar1 bank
Official documents1 document
Listing-day priceOpened at ₹48 on debut
Performance since listingComputed from our own daily closes

Led by Fast Track Finsec Private Limited — median −47.4% across the 11 of its issues we can price. All lead managers →

What happens when

7 AugPre-apply
8 AugBidding opens
12 AugBidding closes
14 AugAllotment
14 AugRefunds
18 AugListing
23 SeptMandate ends

Track MEDISTEP HEALTHCARE LTD

Results, orders, board decisions and every other filing — summarised and sent to your WhatsApp the minute they are out.

Open the company page

Figures are as published by the exchanges and the issuer’s prospectus. MarketPing publishes facts, comparisons and history only — nothing here is a recommendation to apply to this issue, and we do not publish grey market premium.